# Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck

> **NCT01301248** · PHASE2 · UNKNOWN · sponsor: **Theagenio Cancer Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Head and Neck Neoplasms
- AJCC Stage III/IV

## Interventions

- **OTHER:** Chemoradiation plus Cetuximab
- **OTHER:** Chemoradiation

## Key facts

- **NCT ID:** NCT01301248
- **Lead sponsor:** Theagenio Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-03
- **Primary completion:** 2011-04
- **Final completion:** 2011-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2011-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01301248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01301248, "Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01301248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*